AI Engines For more Details: Perplexity Kagi Labs You
Treatment of Depression: Fluvoxamine maleate is primarily used for the treatment of depression, including major depressive disorder (MDD). It helps alleviate symptoms of depression by increasing the levels of serotonin, a neurotransmitter associated with mood regulation, in the brain.
Management of Obsessive-Compulsive Disorder (OCD): Fluvoxamine is also FDA-approved for the treatment of obsessive-compulsive disorder (OCD). It can help reduce the frequency and severity of obsessive thoughts and compulsive behaviors characteristic of OCD.
Social Anxiety Disorder (Social Phobia): Fluvoxamine may be prescribed off-label for the treatment of social anxiety disorder (social phobia). It can help alleviate symptoms of anxiety in social situations and improve overall functioning.
Generalized Anxiety Disorder (GAD): Some healthcare providers may prescribe fluvoxamine off-label for the treatment of generalized anxiety disorder (GAD). It may help reduce excessive worrying, tension, and other symptoms associated with GAD.
Panic Disorder: Fluvoxamine may be used off-label for the treatment of panic disorder, particularly in cases where other medications have been ineffective or poorly tolerated. It can help reduce the frequency and severity of panic attacks.
Post-Traumatic Stress Disorder (PTSD): Fluvoxamine may be prescribed off-label for the treatment of post-traumatic stress disorder (PTSD). It can help alleviate symptoms such as intrusive thoughts, nightmares, hypervigilance, and avoidance behaviors.
Premenstrual Dysphoric Disorder (PMDD): Fluvoxamine may be used off-label for the treatment of premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome (PMS) characterized by significant mood disturbances. It can help alleviate symptoms such as irritability, mood swings, and tension.
Other Conditions: Fluvoxamine may also have potential efficacy in other psychiatric conditions, such as eating disorders (e.g., binge-eating disorder), body dysmorphic disorder, and certain impulse control disorders.
Side Effects: Common side effects of fluvoxamine may include nausea, vomiting, diarrhea, dizziness, drowsiness, headache, insomnia, and sexual dysfunction. It may also increase the risk of suicidal thoughts and behaviors, particularly in young adults and adolescents.
Drug Interactions: Fluvoxamine may interact with other medications, including other antidepressants, certain antibiotics, anticoagulants, antiplatelet drugs, and medications metabolized by the cytochrome P450 system. It is important to inform healthcare providers about all medications, supplements, and herbal products being taken to avoid potential interactions.
Monitoring: Patients taking fluvoxamine may require regular monitoring of symptoms, especially during the initial weeks of treatment and after dosage adjustments. Close monitoring is necessary to assess for treatment response, side effects, and potential emergence of suicidal thoughts or behaviors.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 2 | Escherichia | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Candida | genus | Decreases |
0 | 1 | Staphylococcus | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Parolsenella | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 2 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 2 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 2 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 2 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 2 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 2 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 2 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 2 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 2 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 2 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 2 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 2 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 2 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 2 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 2 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 2 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 2 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 2 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 2 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 2 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 2 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 2 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 2 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 2 | Escherichia coli O103 | serogroup | Decreases |
0 | 2 | Escherichia coli O111 | serogroup | Decreases |
0 | 2 | Escherichia coli O119 | serogroup | Decreases |
0 | 2 | Escherichia coli O121 | serogroup | Decreases |
0 | 2 | Escherichia coli O145 | serogroup | Decreases |
0 | 2 | Escherichia coli O155 | serogroup | Decreases |
0 | 2 | Escherichia coli O157 | serogroup | Decreases |
0 | 2 | Escherichia coli O177 | serogroup | Decreases |
0 | 2 | Escherichia coli O26 | serogroup | Decreases |
0 | 2 | Escherichia coli O3 | serogroup | Decreases |
0 | 2 | Escherichia coli O43 | serogroup | Decreases |
0 | 2 | Escherichia coli O5 | serogroup | Decreases |
0 | 2 | Escherichia coli O78 | serogroup | Decreases |
0 | 2 | Escherichia coli O86 | serogroup | Decreases |
0 | 2 | Escherichia coli O91 | serogroup | Decreases |
0 | 2 | Escherichia coli H20 | serotype | Decreases |
0 | 2 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 2 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 2 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 2 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 2 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 2 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 2 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 2 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 2 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 2 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 2 | Escherichia coli O111:H- | serotype | Decreases |
0 | 2 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 2 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 2 | Escherichia coli O111:NM | serotype | Decreases |
0 | 2 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 2 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 2 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 2 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 2 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 2 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 2 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 2 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 2 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 2 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 2 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 2 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 2 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 2 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 2 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 2 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 2 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 2 | Escherichia coli O145:NM | serotype | Decreases |
0 | 2 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 2 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 2 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 2 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 2 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 2 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 2 | Escherichia coli O157:H- | serotype | Decreases |
0 | 2 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 2 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 2 | Escherichia coli O157:NM | serotype | Decreases |
0 | 2 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 2 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 2 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 2 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 2 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 2 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 2 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 2 | Escherichia coli O177:NM | serotype | Decreases |
0 | 2 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 2 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 2 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 2 | Escherichia coli O25:NM | serotype | Decreases |
0 | 2 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 2 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 2 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 2 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 2 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 2 | Escherichia coli O39:NM | serotype | Decreases |
0 | 2 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 2 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 2 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 2 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 2 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 2 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 2 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 2 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 2 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 2 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 2 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 2 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 2 | Escherichia coli O81:NM | serotype | Decreases |
0 | 2 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 2 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 2 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 2 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 2 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 2 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 2 | Escherichia coli O91:NM | serotype | Decreases |
0 | 2 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 2 | Escherichia coli ONT:H33 | serotype | Decreases |
2 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Candida albicans | species | Decreases |
1 | 0 | Pseudomonas aeruginosa | species | Decreases |
1 | 0 | Staphylococcus aureus | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Coprobacter secundus | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
0 | 1 | Barnesiella viscericola | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Coprococcus comes | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Bacteroides faecium | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Coprobacter fastidiosus | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Prevotella intermedia | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Parafannyhessea umbonata | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Bacteroides caecimuris | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Butyricimonas faecalis | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Leyella lascolaii | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Bifidobacterium bifidum | species | Decreases |
0 | 1 | Roseburia intestinalis | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Parabacteroides merdae | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | Bacteroides nordii | species | Decreases |
0 | 1 | Bacteroides intestinalis | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Paraprevotella clara | species | Decreases |
0 | 1 | Prevotella bivia | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Alistipes dispar | species | Decreases |
0 | 1 | Paraprevotella xylaniphila | species | Decreases |
0 | 1 | Alistipes senegalensis | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Alistipes shahii | species | Decreases |
0 | 1 | Olsenella uli | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 169 | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Intestinimonas butyriciproducens | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
0 | 1 | Pseudomonas aeruginosa group | species group | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.4 | 0.4 | |
Acne | 0.5 | 0.4 | 0.25 |
ADHD | 3.7 | 0.7 | 4.29 |
Age-Related Macular Degeneration and Glaucoma | 0.7 | 0.7 | |
Allergic Rhinitis (Hay Fever) | 2.7 | 2.8 | -0.04 |
Allergies | 7.4 | 3.7 | 1 |
Allergy to milk products | 1.9 | 0.9 | 1.11 |
Alopecia (Hair Loss) | 0.9 | 0.1 | 8 |
Alzheimer's disease | 5.3 | 4.9 | 0.08 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 3.2 | 1 | 2.2 |
Ankylosing spondylitis | 4.5 | 0.6 | 6.5 |
Anorexia Nervosa | 0.7 | 1.7 | -1.43 |
Antiphospholipid syndrome (APS) | 1 | 0.1 | 9 |
Asthma | 5.8 | 3.4 | 0.71 |
Atherosclerosis | 2.6 | 1.4 | 0.86 |
Atrial fibrillation | 2.8 | 2.2 | 0.27 |
Autism | 7.8 | 7.5 | 0.04 |
Autoimmune Disease | 0.6 | 0.6 | 0 |
Barrett esophagus cancer | 0.5 | 0.5 | |
benign prostatic hyperplasia | 0.5 | 0.2 | 1.5 |
Biofilm | 2.7 | 2.7 | |
Bipolar Disorder | 1.1 | 1.2 | -0.09 |
Brain Trauma | 1.3 | 1.1 | 0.18 |
Breast Cancer | 0.3 | 0.3 | |
Cancer (General) | 0.8 | 2.4 | -2 |
Carcinoma | 2.6 | 1.9 | 0.37 |
Celiac Disease | 2.8 | 3.5 | -0.25 |
Cerebral Palsy | 2 | 0.7 | 1.86 |
Chronic Fatigue Syndrome | 3.8 | 5 | -0.32 |
Chronic Kidney Disease | 3.3 | 2.7 | 0.22 |
Chronic Lyme | 0.6 | 0.4 | 0.5 |
Chronic Obstructive Pulmonary Disease (COPD) | 2.3 | 1 | 1.3 |
Chronic Urticaria (Hives) | 1 | 1.2 | -0.2 |
Coagulation / Micro clot triggering bacteria | 1.6 | 0.5 | 2.2 |
Cognitive Function | 1.3 | 0.9 | 0.44 |
Colorectal Cancer | 3.3 | 1.9 | 0.74 |
Constipation | 0.9 | 0.4 | 1.25 |
Coronary artery disease | 1.8 | 2.4 | -0.33 |
COVID-19 | 10.5 | 10.8 | -0.03 |
Crohn's Disease | 5.2 | 4.9 | 0.06 |
Cushing's Syndrome (hypercortisolism) | 0.5 | 0.2 | 1.5 |
cystic fibrosis | 1.8 | 1.6 | 0.13 |
d-lactic acidosis (one form of brain fog) | 0.8 | 0.8 | |
deep vein thrombosis | 2.1 | 0.5 | 3.2 |
Denture Wearers Oral Shifts | 1.9 | 1.9 | |
Depression | 7.2 | 7.7 | -0.07 |
Dermatomyositis | 0.5 | 0.4 | 0.25 |
Eczema | 1.6 | 1 | 0.6 |
Endometriosis | 2.6 | 1.7 | 0.53 |
Eosinophilic Esophagitis | 0.5 | -0.5 | |
Epilepsy | 2.5 | 2 | 0.25 |
erectile dysfunction | 0.5 | 0.4 | 0.25 |
Fibromyalgia | 2.5 | 1.3 | 0.92 |
Functional constipation / chronic idiopathic constipation | 3.8 | 2.3 | 0.65 |
gallstone disease (gsd) | 2.2 | 1 | 1.2 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.5 | 1.4 | -1.8 |
Generalized anxiety disorder | 1.9 | 1.7 | 0.12 |
giant cell arteritis | 0 | 0 | |
Gout | 2 | 0.6 | 2.33 |
Graves' disease | 1.5 | 2.3 | -0.53 |
Gulf War Syndrome | 0.3 | 1.7 | -4.67 |
Halitosis | 0.7 | 0.7 | |
Hashimoto's thyroiditis | 2.9 | 1.8 | 0.61 |
Heart Failure | 3.2 | 2.2 | 0.45 |
hemorrhagic stroke | 0.3 | 0.3 | |
Hidradenitis Suppurativa | 1.9 | 0.5 | 2.8 |
High Histamine/low DAO | 0.8 | 0.5 | 0.6 |
hypercholesterolemia (High Cholesterol) | 0.7 | 0.6 | 0.17 |
hyperglycemia | 1.8 | 1.9 | -0.06 |
Hyperlipidemia (High Blood Fats) | 1.3 | 0.3 | 3.33 |
hypersomnia | 0.7 | -0.7 | |
hypertension (High Blood Pressure | 3.9 | 4.8 | -0.23 |
Hypothyroidism | 1.6 | 1 | 0.6 |
Hypoxia | 1.4 | 1.4 | |
IgA nephropathy (IgAN) | 1.2 | 4 | -2.33 |
Inflammatory Bowel Disease | 6.3 | 8.7 | -0.38 |
Insomnia | 2.6 | 3.5 | -0.35 |
Intelligence | 0.8 | 0.6 | 0.33 |
Intracranial aneurysms | 0.7 | 0.3 | 1.33 |
Irritable Bowel Syndrome | 6.6 | 3.8 | 0.74 |
ischemic stroke | 2.8 | 1 | 1.8 |
Juvenile idiopathic arthritis | 0.5 | 0.5 | |
Liver Cirrhosis | 5.8 | 3.7 | 0.57 |
Long COVID | 5 | 7 | -0.4 |
Low bone mineral density | 0.8 | -0.8 | |
Lung Cancer | 0.5 | 1.4 | -1.8 |
Lymphoma | 0.3 | 0.3 | |
Mast Cell Issues / mastitis | 1.5 | 0.5 | 2 |
ME/CFS with IBS | 0.2 | 2.3 | -10.5 |
ME/CFS without IBS | 1.2 | 1.7 | -0.42 |
Menopause | 2.3 | 0.6 | 2.83 |
Metabolic Syndrome | 5.3 | 5.7 | -0.08 |
Mood Disorders | 7.4 | 6.7 | 0.1 |
multiple chemical sensitivity [MCS] | 0.9 | 0.2 | 3.5 |
Multiple Sclerosis | 5.8 | 3.9 | 0.49 |
Multiple system atrophy (MSA) | 1.4 | 0.7 | 1 |
myasthenia gravis | 0.3 | 0.2 | 0.5 |
neuropathic pain | 0.4 | 2.3 | -4.75 |
Neuropathy (all types) | 1.1 | 1 | 0.1 |
neuropsychiatric disorders (PANDAS, PANS) | 0.7 | 0.7 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 4.3 | 5.3 | -0.23 |
NonCeliac Gluten Sensitivity | 2.1 | 0.6 | 2.5 |
Obesity | 9.4 | 5.8 | 0.62 |
obsessive-compulsive disorder | 4 | 3.4 | 0.18 |
Osteoarthritis | 1.7 | 1.3 | 0.31 |
Osteoporosis | 2.2 | 1.6 | 0.38 |
pancreatic cancer | 0.6 | 0.6 | |
Parkinson's Disease | 7.4 | 5 | 0.48 |
Polycystic ovary syndrome | 2.2 | 2.2 | 0 |
Postural orthostatic tachycardia syndrome | 0 | 0.4 | 0 |
Premenstrual dysphoric disorder | 1.2 | 1.2 | |
primary biliary cholangitis | 0.8 | 0.4 | 1 |
Primary sclerosing cholangitis | 1.5 | 1.1 | 0.36 |
Psoriasis | 4.1 | 2.2 | 0.86 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 7.4 | 3.1 | 1.39 |
Rosacea | 1.1 | 0.2 | 4.5 |
Schizophrenia | 6.3 | 2.3 | 1.74 |
scoliosis | 1 | 0.8 | 0.25 |
sensorineural hearing loss | 1.2 | 1.2 | |
Sjögren syndrome | 2.7 | 2 | 0.35 |
Sleep Apnea | 1.6 | 1 | 0.6 |
Slow gastric motility / Gastroparesis | 1.1 | 0.4 | 1.75 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.8 | 0.6 | 2 |
Stress / posttraumatic stress disorder | 2.3 | 2.3 | 0 |
Systemic Lupus Erythematosus | 3.2 | 1.6 | 1 |
Tic Disorder | 0.4 | 2 | -4 |
Tourette syndrome | 0.8 | 0.2 | 3 |
Type 1 Diabetes | 3.7 | 3 | 0.23 |
Type 2 Diabetes | 5.7 | 4.6 | 0.24 |
Ulcerative colitis | 3.1 | 5.2 | -0.68 |
Unhealthy Ageing | 2.7 | 2.1 | 0.29 |
Vitiligo | 1 | 1.2 | -0.2 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]